864244-98-4 Usage
Description
4-(2-Methyl-4-Nitrophenoxy)Pyridin-2-Amine is a pyridinamine derivative with a molecular formula of C12H11N3O3. It features a nitrophenyl group attached to the pyridine ring, making it a valuable building block in the synthesis of pharmaceutical compounds, agrochemicals, and materials science applications, such as organic semiconductors and dyes.
Uses
Used in Pharmaceutical Industry:
4-(2-Methyl-4-Nitrophenoxy)Pyridin-2-Amine is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows it to inhibit specific biological processes, making it a promising candidate for the development of new drugs.
Used in Agrochemical Industry:
In the agrochemical industry, 4-(2-Methyl-4-Nitrophenoxy)Pyridin-2-Amine is utilized as a precursor in the production of pesticides. Its ability to interfere with biological pathways makes it a potential component in creating effective pest control solutions.
Used in Materials Science:
4-(2-Methyl-4-Nitrophenoxy)Pyridin-2-Amine is used as a component in the development of organic semiconductors and dyes. Its chemical properties contribute to the creation of innovative materials with potential applications in various fields.
It is crucial to handle 4-(2-Methyl-4-Nitrophenoxy)Pyridin-2-Amine with care and follow proper safety protocols due to its potential hazards.
Check Digit Verification of cas no
The CAS Registry Mumber 864244-98-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,4,2,4 and 4 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 864244-98:
(8*8)+(7*6)+(6*4)+(5*2)+(4*4)+(3*4)+(2*9)+(1*8)=194
194 % 10 = 4
So 864244-98-4 is a valid CAS Registry Number.
864244-98-4Relevant articles and documents
ALKYNYL QUINAZOLINE COMPOUNDS
-
Paragraph 0858, (2021/02/19)
The present disclosure relates to compounds of Formula (I'): and pharmaceutically acceptable salts and stereoisomers thereof. The present disclosure also relates to methods of preparation these compounds, compositions comprising these compounds, and methods of using them in the prevention or treatment of abnormal cell growth in mammals, especially humans.
Synthesis method of Tucatinib and intermediate product thereof
-
, (2020/11/09)
The invention discloses a synthesis method of Tucatinib, and the method comprises the following step: carrying out substitution reaction on halate of a compound shown in a formula VI or free alkali thereof serving as a raw material and a compound shown in a formula VII under an alkaline condition to obtain a compound shown in a formula VIII. The raw materials used in the whole synthesis route areeasy to obtain, expensive catalysts are not needed, and the method is suitable for large-scale production and beneficial to industrial production of the Tucatinib.
ERBB RECEPTOR INHIBITORS
-
Page/Page column 58, (2019/11/28)
Disclosed are compounds inhibiting ErbBs (e. g. HER2), pharmaceutically acceptable salts, hydrates, solvates or stereoisomers thereof and pharmaceutical compositions comprising the compounds. The compound and the pharmaceutical composition can effectively treat diseases associated ErbBs (especially HER2), including cancer.
